Tocilizumab cuts progression to ventilation or death in COVID-19
(HealthDay)—Tocilizumab reduces the risk for progression to ventilation or death among hospitalized patients with COVID-19 pneumonia, according to a study
Read more
(HealthDay)—Tocilizumab reduces the risk for progression to ventilation or death among hospitalized patients with COVID-19 pneumonia, according to a study
Read more